BR0214340A - Método para controle da angiogênese em animais - Google Patents

Método para controle da angiogênese em animais

Info

Publication number
BR0214340A
BR0214340A BR0214340-2A BR0214340A BR0214340A BR 0214340 A BR0214340 A BR 0214340A BR 0214340 A BR0214340 A BR 0214340A BR 0214340 A BR0214340 A BR 0214340A
Authority
BR
Brazil
Prior art keywords
animals
angiogenesis
polymeric structure
controlling angiogenesis
therapeutic materials
Prior art date
Application number
BR0214340-2A
Other languages
English (en)
Inventor
Yan Chang
Vodek Sasak
Original Assignee
Glycogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycogenesys Inc filed Critical Glycogenesys Inc
Publication of BR0214340A publication Critical patent/BR0214340A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"MéTODO PARA CONTROLE DA ANGIOGêNESE EM ANIMAIS". As condições de doenças que são dependentes ou moderadas pela angiogênese são controladas pelo uso de um material terapêutico que interage com galectinas da superfície celular. Materiais terapêuticos particulares compreendem uma estrutura polimérica que apresenta cadeias laterais com extremidade ligada a um açúcar. Os materiais terapêuticos específicos estão descritos onde a estrutura polimérica é composta de ácido poligalacturónico e a extremidade das cadeias laterais em arabinose ou galactose.
BR0214340-2A 2001-11-21 2002-11-21 Método para controle da angiogênese em animais BR0214340A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33179301P 2001-11-21 2001-11-21
US10/299,478 US6890906B2 (en) 2001-11-21 2002-11-19 Method for controlling angiogenesis in animals
PCT/US2002/037400 WO2003045908A2 (en) 2001-11-21 2002-11-21 Method for controlling angiogenesis in animals

Publications (1)

Publication Number Publication Date
BR0214340A true BR0214340A (pt) 2004-09-14

Family

ID=26971240

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214340-2A BR0214340A (pt) 2001-11-21 2002-11-21 Método para controle da angiogênese em animais

Country Status (10)

Country Link
US (1) US6890906B2 (pt)
EP (1) EP1451227A4 (pt)
JP (1) JP2005521644A (pt)
CN (1) CN1636020A (pt)
AU (1) AU2002348316A1 (pt)
BR (1) BR0214340A (pt)
CA (1) CA2467451A1 (pt)
IL (1) IL161763A0 (pt)
MX (1) MXPA04004873A (pt)
WO (1) WO2003045908A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121981A1 (en) * 2001-11-21 2004-06-24 Glycogenesys, Inc. Method for controlling angiogenesis in animals
EP1980257A1 (en) 2003-04-07 2008-10-15 Prospect Therapeutics, Inc. Compositions and uses of galectin antagonists
US20050158321A1 (en) * 2003-12-17 2005-07-21 Entelos, Inc. Treatment of rheumatoid arthritis with galectin-3 antagonists
US8128966B2 (en) 2004-03-26 2012-03-06 La Jolla Pharmaceutical Company Modified pectins, compositions and methods related thereto
US20060014719A1 (en) * 2004-07-13 2006-01-19 Glycogenesys, Inc. Method for treating neurodegenerative diseases
US9427449B2 (en) * 2005-08-26 2016-08-30 Econugenics, Inc. Binding of galectin-3 by low molecular weight pectin
FR2916353B1 (fr) * 2007-05-25 2010-09-24 Univ Picardie Composition pharmaceutique destinee a preserver le collagene
BR112014015940B1 (pt) 2011-12-28 2022-08-09 Galectin Therapeutics, Inc Polissacarídeo de grau farmacêutico, composição, e seus usos
BR112014030534A2 (pt) 2012-06-06 2017-06-27 Galectin Therapeutics Inc composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada
WO2014043708A1 (en) 2012-09-17 2014-03-20 Traber Peter G Method for enhancing specific immunotherapies in cancer treatment
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
CN104955471A (zh) * 2012-11-15 2015-09-30 塔夫斯大学 使用半乳糖凝集素蛋白抑制剂用于治疗、调节或预防受试者的眼部血管生成或者纤维化的方法、组合物以及试剂盒
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
AU2015229658A1 (en) * 2014-03-10 2016-09-29 La Jolla Pharmaceutical Company Compositions and methods for treating kidney disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834442A (en) 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
US5681923A (en) 1995-10-06 1997-10-28 Platt; David Tumor derived carbohydrate binding protein
US6632797B2 (en) * 1996-06-24 2003-10-14 Matti Siren Method of treating angiogenesis
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
CA2279791C (en) 1998-08-14 2011-11-08 Marcus B. Gohlke Dietary supplement combining colostrum and lactorferrin in a mucosal delivery format
US6500807B1 (en) 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
US6680306B2 (en) 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies

Also Published As

Publication number Publication date
EP1451227A2 (en) 2004-09-01
WO2003045908A3 (en) 2003-08-07
IL161763A0 (en) 2005-11-20
CA2467451A1 (en) 2003-06-05
MXPA04004873A (es) 2004-07-30
WO2003045908A2 (en) 2003-06-05
US6890906B2 (en) 2005-05-10
US20030100535A1 (en) 2003-05-29
AU2002348316A1 (en) 2003-06-10
EP1451227A4 (en) 2005-06-15
JP2005521644A (ja) 2005-07-21
CN1636020A (zh) 2005-07-06

Similar Documents

Publication Publication Date Title
BR0214340A (pt) Método para controle da angiogênese em animais
DE69429015T2 (de) Mit kautschukkrümeln verstärkter zementbeton
BRPI0417980A (pt) tela para o uso em um revestimento para uma estrutura de edifìcio
ATE227795T1 (de) Zementhaltige bauplatte mit verstärkten kanten
WO2001051278A8 (fr) Materiau impermeable a l'eau a base de ciment transformable et de polymere flexible ainsi que son procede de preparation
BR0014125A (pt) Terpolìmeros halogenados de isobutileno, monÈmero de diolefina e monÈmero estirênico
BRPI0410884A (pt) composição de ração para uso em um animal de estimação, e, método para o controle de peso em um animal de estimação
SE9103101L (sv) Brandsaekert taeckmaterial
ES2167896T3 (es) Cargas superficialmente modificadas, de tipo oxido o silicato y su empleo.
EA199801070A1 (ru) Обеспечение устойчивости мостов
AU6051390A (en) Lifting cramp, mainly for raising concrete slabs
BR9814896A (pt) Processo para a preparação de polìmeros hidrossolúveis ou intumescìveis na água com teor de monÈmeros restantes muito baixo, produtos preparados pelo mesmo e seu emprego
SE7702697L (sv) Festelement for tre, lettbetong, gips mm
SE8802421D0 (sv) Oppet graderad asfalt
FR2638743B1 (fr) Methyl-2 tertiobutyl-5 thiophenol, son procede de preparation et son application
ATE65771T1 (de) Putz-system.
ATE74579T1 (de) Selbstnivellierende moertelmischung.
ES2067288T3 (es) Pinturas para fachadas y revoques con alta resistencia al agua temprana.
ATE23033T1 (de) Stabile zementzusammensetzung.
BRPI0415366A (pt) composição de efeito prolongado para controlar parasitas internos e externos aos animais, e, uso da mesma
BR9105923A (pt) Composicao para uso como uma solucao ou dispersao aquosa auxiliar de enxaguandura no tratamento de plastico ou superficies pintadas,mistura de tensoativos,solucao ou dispersao,aquosa de uma composicao,e,processo para o tratamento de plasticos osuperficies pintadas
NO903321L (no) Vaate ugarvede huder som er biologisk stabile og fremgangsmaate for deres fremstilling.
ES2093726T3 (es) Material termoaislante para construcciones de proteccion contra incendios.
Lopez Diaz CIB W83 member collaborates
HARRE RENDERING OF MASONRY BUILT OF POROTON BRICKS.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.